Response of exercise-onset vasodilator kinetics to L-citrulline supplementation during different phases of the menstrual cycle.
運動開始時の血管拡張反応動態に対するL-シトルリン補給の月経周期各期における影響 (機械翻訳の邦題)
記録の確認項目
- 研究デザイン
- ランダム化比較試験
- 対象
- ヒト
- 出版年
- 2020
- 出典
- doi.org
- 抄録の表示
- 表示あり
- 出版状態
- 有効な記録
- 状態確認日
- 2026/08/17
- 収集日
- 2026/08/13
- 鮮度
- 確認期限内
- 確認段階
- 自動処理
- 記録状態
- 公開
日本語要約(機械生成)
本研究は、月経周期の卵胞期と黄体期におけるL-シトルリン(CIT)補給が、動的収縮中の筋における血管拡張反応動態に異なる影響を及ぼすか検討した。対象は若年健康女性24名で、卵胞期群(月経開始15日目、n=13)と黄体期群(同25日目、n=11)に分け、CIT(6g/日)またはプラセボを7日間摂取するクロスオーバー試験を2周期行った。最大握力の10%でのハンドグリップ運動中に前腕血管コンダクタンス(FVC)を連続測定し、各デューティサイクルでの変化量(ΔFVC)を単一指数モデルで近似した。その結果、ΔFVCの振幅はCITとプラセボ間(p=.45)および月経周期相間(p=.11)で差がなく、時定数(τΔFVC)もCITとプラセボ間で差はなかった(p=.35)が、黄体期のτΔFVCは卵胞期より遅かった(8±4対5±3デューティサイクル、p=.02)。以上より、若年健康女性においてCIT補給は月経周期相にかかわらず運動開始時の血管拡張反応動態を変化させないことが示された。
この要約は公開抄録のみを根拠にAIが機械的に生成したものです。正確な内容は原文を確認してください。
抄録
The purpose of this study was to determine whether L-citrulline (CIT) supplementation during the follicular and luteal phases of the menstrual cycle would present differential effects on vasodilator kinetics in dynamically contracting muscle. Twenty-four women were studied during the follicular (day 15 after onset of menses, n = 13) or the luteal phase (day 25 after onset of menses, n = 11). Supplementation with CIT (6g/day) or placebo occurred 7-days prior to testing in a crossover design across two menstrual cycles. Forearm vascular conductance (FVC) was calculated from blood flow and mean arterial pressure measured continuously during handgrip exercise performed at 10% maximal grip strength. FVC was calculated for each duty cycle (contract:relax, 1:2s) and expressed as a change from baseline (ΔFVC) before being fit with a monoexponential model. Amplitude of the ΔFVC response and the number of duty cycles for ΔFVC to reach 63% of steady-state amplitude (τΔFVC) were derived from the model. Analysis of variance showed no difference in the amplitude of ΔFVC between CIT and placebo (p = .45) or between menstrual cycle phases (p = .11). Additionally, τΔFVC was not different (p = .35) between CIT and placebo in women tested during the follicular (6 ± 3 versus 5 ± 3 duty cycles) or luteal phase (9 ± 1 versus 8 ± 1 duty cycles) although τΔFVC was found to be slower for women tested during the luteal as compared to the follicular phase (8 ± 4 versus 5 ± 3 duty cycles, p = .02). These results indicate that exercise-onset vasodilator kinetics is unaltered with CIT supplementation in young healthy women irrespective of menstrual cycle phase.
MeSH
DOI 10.14814/phy2.14536
PMID 32776464
原文・出典を見る →